BioSpectrum India: BioPharma, Healthcare, healthscience, Biotechnology, BioIT, Pharma news updates

SCIENCE

Science | 18 May 2022 | News

India lags behind other nations in actively promoting science: Study

Research communication attracts funders, increases opportunities for multi-institutional collaborations and mu...Read more

OPINION

Opinion | 17 May 2022 | Views

Growth of therapeutic respiratory devices market in India

Breathing difficulties are an issue that affects millions of people every day, all around the world. It might ...Read more

ANALYSIS

Special | 30 April 2022 | Features

Indian biopharma industry hits Rs 33k crore with 13% growth in 2020-21

Amidst the pandemic, the Indian Biopharma Industry, with over 300 companies, has witnessed a good growth of 13...Read more

START-UPS

Start-ups | 18 May 2022 | News

Guwahati Biotech Park & IIT-G announce ASSAM BIOTECH CONCLAVE 2022

A state-of-the-art Technology Incubator Centre (TIC) with an incubation space of 1,00,000 sq ft has been ...Read more

SUPPLIER

Supplier | 17 May 2022 | News

PerkinElmer expands genomic testing services with urWGS

PerkinElmer has announced the availability of ultrarapid whole genome sequencing (urWGS) through PerkinElmer G...Read more

PEOPLE

People | 19 May 2022 | News

Dr Nina Kottler joins Synapsica’s Advisory Board

Dr Nina Kottler, Associate Chief Medical Officer for Clinical Artificial Intelligence at Radiology Partners, h...Read more

ACADEMICS

Academics | 21 May 2022 | News

MedLern, BMJ Publishing Group launch CPD courses for Indian nurses

MedLern and BMJ Publishing Group (British Medical Journal publishing group) have teamed up to provide via its ...Read more

BLOGS

Blogs | 08 May 2022 | Views

Returning Mothers: Upskilling Their Way in Their Career

Whether you are a mother who has been out of the workplace for one year or ten years, the thought of restartin...Read more

Videos

Inside Magazine

Indian biopharma industry HITS Rs 33K Cr WITH 13% GROWTH in 2020-21

Amidst the pandemic, the Indian Biopharma Industry, with over 300 companies, has witnessed a good growth of 13 percent, 2 percent less than the previous year’s 15 percent growth rate. This growth was largely driven by the performance of the Indian biopharma companies which have done very well as against multinational companies. As a result, the Indian Biopharma Industry has crossed the Rs 33,000 crore mark for the year 2020-21 over the previous year’s figure of Rs 29,176 crore. The Indian Biopharma industry, comprising hormones, insulin, blood products, and vaccines recorded a sales revenue of Rs 33,067 crore for the year 2020-21.

For Feedback, please email us at : communications@mmactiv.com